{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:55:39Z","timestamp":1790952939085,"version":"4.1.0"},"reference-count":32,"publisher":"Pleiades Publishing Ltd","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1134\/s0006297926601292","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:31:00Z","timestamp":1790951460000},"page":"1704-1715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Celastrol Sensitizes Bladder Cancer to Gemcitabine by Regulating LINC00839-Mediated Homologous Recombination DNA Repair"],"prefix":"10.1134","volume":"91","author":[{"given":"Bo","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueshui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"3097_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L. Dyrskjot","year":"2023","unstructured":"Dyrskjot, L., Hansel, D. E., Efstathiou, J. A., Knowles, M. A., Galsky, M. D., Teoh, J., and Theodorescu, D. (2023) Bladder cancer, Nat. Rev. Dis. Primers, 9, 58, \nhttps:\/\/doi.org\/10.1038\/s41572-023-00468-9.","journal-title":"Nat. Rev. Dis. Primers"},{"key":"3097_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41571-025-01104-z","volume":"23","author":"M. P. St-Laurent","year":"2026","unstructured":"St-Laurent, M. P., Nikkola, J., Tomiyama, E., and Black, P. C. (2026) Advances in the management of localized bladder cancers, Nat. Rev. Clin. Oncol., 23, 158-179, \nhttps:\/\/doi.org\/10.1038\/s41571-025-01104-z.","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"3097_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103990","volume":"89","author":"R. Liu","year":"2025","unstructured":"Liu, R., Ma, R., Zhang, N., Geng, X., Li, J., Zhu, L., and Li, Z. (2025) Celastrol nanomedicine eye drops restore redox homeostasis and prevents keratoconus progression via PI3K\/AKT\/AP-1 signaling, Redox Biol., 89, 103990, \nhttps:\/\/doi.org\/10.1016\/j.redox.2025.103990.","journal-title":"Redox Biol."},{"key":"3097_CR4","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2025.508","author":"Y. Yan","year":"2025","unstructured":"Yan, Y., Qiu, C., Fu, W., Shu, C., Xu, C., Chen, Y., Xia, Y., Chen, J., Chen, Y., Cui, R., Zou, P., and Ni, D. (2025) Synergistic anticancer effects of lenvatinib and celastrol via ROS-mediated ER stress and JNK signaling in colon cancer cells, Cancer Res. Treat., \nhttps:\/\/doi.org\/10.4143\/crt.2025.508.","journal-title":"Cancer Res. Treat."},{"key":"3097_CR5","doi-asserted-by":"publisher","first-page":"14327","DOI":"10.1007\/s00210-025-04148-1","volume":"398","author":"M. M. Salama","year":"2025","unstructured":"Salama, M. M., Zaghloul, R. A., Khalil, R. M., and El-Shishtawy, M. M. (2025) Anti-neoplastic activity of celastrol in experimentally-induced mammary adenocarcinoma in mice: targeting Wnt\/\u03b2-catenin signaling pathway, Naunyn Schmiedebergs Arch. Pharmacol., 398, 14327-14339, \nhttps:\/\/doi.org\/10.1007\/s00210-025-04148-1.","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"3097_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407681","volume":"12","author":"Z. Deng","year":"2025","unstructured":"Deng, Z., Sun, S., Zhou, N., Peng, Y., Cheng, L., Yu, X., Yuan, Y., Guo, M., Xu, M., Cheng, Y., Zhou, F., Li, N., Yang, Y., and Gu, C. (2025) PNPO-mediated oxidation of DVL3 promotes multiple myeloma malignancy and osteoclastogenesis by activating the Wnt\/\u03b2-catenin pathway, Adv. Sci. (Weinh.), 12, e2407681, \nhttps:\/\/doi.org\/10.1002\/advs.202407681.","journal-title":"Adv. Sci. (Weinh.)"},{"key":"3097_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70641","volume":"39","author":"M. Z. Nasrullah","year":"2025","unstructured":"Nasrullah, M. Z., Fahmy, U. A., Abdel-Naim, A. B., Babekir, E. Y., Alhothaly, A. H., Elmesilhy, A. M., Albalawi, R. S., and Hofni, A. (2025) Celastrol mitigates colistin-induced renal toxicity in rats via modulating Nrf-2\/HO-1 and NF-\u03baB signaling pathways, J. Biochem. Mol. Toxicol., 39, e70641, \nhttps:\/\/doi.org\/10.1002\/jbt.70641.","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"3097_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2018.12.028","volume":"58","author":"M. J. Hsieh","year":"2019","unstructured":"Hsieh, M. J., Wang, C. W., Lin, J. T., Chuang, Y. C., Hsi, Y. T., Lo, Y. S., Lin, C. C., and Chen, M. K. (2019) Celastrol, a plant-derived triterpene, induces cisplatin-resistance nasopharyngeal carcinoma cancer cell apoptosis through ERK1\/2 and p38 MAPK signaling pathway, Phytomedicine, 58, 152805, \nhttps:\/\/doi.org\/10.1016\/j.phymed.2018.12.028.","journal-title":"Phytomedicine"},{"key":"3097_CR9","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3892\/ijo.2018.4276","volume":"52","author":"Y. J. Li","year":"2018","unstructured":"Li, Y. J., Sun, Y. X., Hao, R. M., Wu, P., Zhang, L. J., Ma, X., Ma, Y., Wang, P. Y., Xie, N., Xie, S. Y., and Chen, W. (2018) miR-33a-5p enhances the sensitivity of lung adenocarcinoma cells to celastrol by regulating mTOR signaling, Int. J. Oncol., 52, 1328-1338, \nhttps:\/\/doi.org\/10.3892\/ijo.2018.4276.","journal-title":"Int. J. Oncol."},{"key":"3097_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.105113","volume":"218","author":"Z. Zhang","year":"2026","unstructured":"Zhang, Z., Peng, W., Zhao, B., Meng, L., and Pan, J. (2026) Long noncoding RNAs as master regulators of autophagy in cancer: implications for chemoresistance and therapeutic sensitization, Crit. Rev. Oncol. Hematol., 218, 105113, \nhttps:\/\/doi.org\/10.1016\/j.critrevonc.2025.105113.","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"3097_CR11","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.7150\/jca.93820","volume":"15","author":"Y. Hu","year":"2024","unstructured":"Hu, Y., Hu, Y., Lu, X., Luo, H., and Chen, Z. (2024) LINC00839 in human disorders: insights into its regulatory roles and clinical impact, with a special focus on cancer, J. Cancer, 15, 2179-2192, \nhttps:\/\/doi.org\/10.7150\/jca.93820.","journal-title":"J. Cancer"},{"key":"3097_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2270106","volume":"24","author":"Z. Wang","year":"2023","unstructured":"Wang, Z., Wei, B., and Ma, S. (2023) EGR1\/LINC00839\/SOX5 axis modulates migration, invasion and gemcitabine resistance of bladder cancer cells, Cancer Biol. Ther., 24, 2270106, \nhttps:\/\/doi.org\/10.1080\/15384047.2023.2270106.","journal-title":"Cancer Biol. Ther."},{"key":"3097_CR13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrm.2017.67","volume":"18","author":"J. C. Saldivar","year":"2017","unstructured":"Saldivar, J. C., Cortez, D., and Cimprich, K. A. (2017) The essential kinase ATR: ensuring faithful duplication of a challenging genome, Nat. Rev. Mol. Cell Biol., 18, 622-636, \nhttps:\/\/doi.org\/10.1038\/nrm.2017.67.","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3097_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-016-0473-1","volume":"36","author":"M. Isono","year":"2017","unstructured":"Isono, M., Hoffmann, M. J., Pinkerneil, M., Sato, A., Michaelis, M., Cinatl, J., Jr., Niegisch, G., and Schulz, W. A. (2017) Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine, J. Exp. Clin. Cancer Res., 36, 1, \nhttps:\/\/doi.org\/10.1186\/s13046-016-0473-1.","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"3097_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41573-024-01060-w","volume":"24","author":"Y. Drew","year":"2025","unstructured":"Drew, Y., Zenke, F. T., and Curtin, N. J. (2025) DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications, Nat. Rev. Drug Discov., 24, 19-39, \nhttps:\/\/doi.org\/10.1038\/s41573-024-01060-w.","journal-title":"Nat. Rev. Drug Discov."},{"key":"3097_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1173-4","volume":"38","author":"X. Liu","year":"2019","unstructured":"Liu, X., Zhao, P., Wang, X., Wang, L., Zhu, Y., Song, Y., and Gao, W. (2019) Celastrol mediates autophagy and apoptosis via the ROS\/JNK and Akt\/mTOR signaling pathways in glioma cells, J. Exp. Clin. Cancer Res., 38, 184, \nhttps:\/\/doi.org\/10.1186\/s13046-019-1173-4.","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"3097_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00025","volume":"11","author":"Y. Zhu","year":"2020","unstructured":"Zhu, Y., Liu, X., Zhao, P., Zhao, H., Gao, W., and Wang, L. (2020) Celastrol suppresses glioma vasculogenic mimicry formation and angiogenesis by blocking the PI3K\/Akt\/mTOR signaling pathway, Front. Pharmacol., 11, 25, \nhttps:\/\/doi.org\/10.3389\/fphar.2020.00025.","journal-title":"Front. Pharmacol."},{"key":"3097_CR18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/jnc.12474","volume":"128","author":"S. Chen","year":"2014","unstructured":"Chen, S., Gu, C., Xu, C., Zhang, J., Xu, Y., Ren, Q., Guo, M., Huang, S., and Chen, L. (2014) Celastrol prevents cadmium-induced neuronal cell death via targeting JNK and PTEN-Akt\/mTOR network, J. Neurochem., 128, 256-266, \nhttps:\/\/doi.org\/10.1111\/jnc.12474.","journal-title":"J. Neurochem."},{"key":"3097_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.tcb.2024.06.008","volume":"35","author":"V. Kalamara","year":"2025","unstructured":"Kalamara, V., and Garinis, G. A. (2025) The epitranscriptome: reshaping the DNA damage response, Trends Cell Biol., 35, 294-304, \nhttps:\/\/doi.org\/10.1016\/j.tcb.2024.06.008.","journal-title":"Trends Cell Biol."},{"key":"3097_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1390300","volume":"15","author":"Z. Gao","year":"2024","unstructured":"Gao, Z., Luan, X., Wang, X., Han, T., Li, X., Li, Z., Li, P., and Zhou, Z. (2024) DNA damage response-related ncRNAs as regulators of therapy resistance in cancer, Front. Pharmacol., 15, 1390300, \nhttps:\/\/doi.org\/10.3389\/fphar.2024.1390300.","journal-title":"Front. Pharmacol."},{"key":"3097_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2430029","volume":"56","author":"Y. Sun","year":"2024","unstructured":"Sun, Y., Zhen, F., Wang, H., Liang, X., Wang, Y., Wang, F., and Hu, J. (2024) Exosomal long non-coding RNA-LINC00839 promotes lung adenocarcinoma progression by activating NF-\u03baB signaling pathway, Ann. Med., 56, 2430029, \nhttps:\/\/doi.org\/10.1080\/07853890.2024.2430029.","journal-title":"Ann. Med."},{"key":"3097_CR22","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s11064-022-03613-0","volume":"47","author":"Q. Zhang","year":"2022","unstructured":"Zhang, Q., Wei, J., Li, N., and Liu, B. (2022) LINC00839 promotes neuroblastoma progression by sponging miR-454-3p to up-regulate NEUROD1, Neurochem. Res., 47, 2278-2293, \nhttps:\/\/doi.org\/10.1007\/s11064-022-03613-0.","journal-title":"Neurochem. Res."},{"key":"3097_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09602-4","volume":"22","author":"H. Wen","year":"2022","unstructured":"Wen, H., Feng, Z., Ma, Y., Liu, R., Ou, Q., Guo, Q., Shen, Y., Wu, X., Shao, Y., Bao, H., and Wu, X. (2022) Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer, BMC Cancer, 22, 550, \nhttps:\/\/doi.org\/10.1186\/s12885-022-09602-4.","journal-title":"BMC Cancer"},{"key":"3097_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.20517\/cdr.2023.08","volume":"6","author":"T. Zielli","year":"2023","unstructured":"Zielli, T., Labidi-Galy, I., Del Grande, M., Sessa, C., and Colombo, I. (2023) The clinical challenges of homologous recombination proficiency in ovarian cancer: from intrinsic resistance to new treatment opportunities, Cancer Drug Resist., 6, 499-516, \nhttps:\/\/doi.org\/10.20517\/cdr.2023.08.","journal-title":"Cancer Drug Resist."},{"key":"3097_CR25","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41417-024-00815-2","volume":"31","author":"T. D. Bazan Russo","year":"2024","unstructured":"Bazan Russo, T. D., Mujacic, C., Di Giovanni, E., Vitale, M. C., Ferrante Bannera, C., Randazzo, U., Contino, S., Bono, M., Gristina, V., Galvano, A., Perez, A., Badalamenti, G., Russo, A., Bazan, V., and Incorvaia, L. (2024) Pol\u03b8: emerging synthetic lethal partner in homologous recombination-deficient tumors, Cancer Gene Ther., 31, 1619-1631, \nhttps:\/\/doi.org\/10.1038\/s41417-024-00815-2.","journal-title":"Cancer Gene Ther."},{"key":"3097_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI180106","volume":"135","author":"S. Ma","year":"2025","unstructured":"Ma, S., Han, Y., Gu, R., Chen, Q., Guo, Q., Yue, Y., Cao, C., Liu, L., Yang, Z., Qin, Y., Yang, Y., Zhang, K., Liu, F., Liu, L., Yang, N., Hao, J., Yang, J., Yao, Z., Mao, X., and Shi, L. (2025) Auranofin attenuates TOPBP1-mediated ATR replication stress response and improves chemotherapeutic response in breast tumor models, J. Clin. Invest., 135, e180106, \nhttps:\/\/doi.org\/10.1172\/JCI180106.","journal-title":"J. Clin. Invest."},{"key":"3097_CR27","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1111\/cas.15845","volume":"114","author":"K. Yano","year":"2023","unstructured":"Yano, K., and Shiotani, B. (2023) Emerging strategies for cancer therapy by ATR inhibitors, Cancer Sci., 114, 2709-2721, \nhttps:\/\/doi.org\/10.1111\/cas.15845.","journal-title":"Cancer Sci."},{"key":"3097_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-025-01082-z","volume":"31","author":"L. Pei","year":"2025","unstructured":"Pei, L., Zhu, Y., Li, W., Xu, B., and Sun, J. (2025) Celastrol promotes DNA damage and apoptosis in uterine corpus endometrial carcinoma via promotion of KAT2B-mediated RBPJ acetylation and repression of MCM4 transcription, Mol. Med., 31, 39, \nhttps:\/\/doi.org\/10.1186\/s10020-025-01082-z.","journal-title":"Mol. Med."},{"key":"3097_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115815","volume":"169","author":"F. Wen","year":"2023","unstructured":"Wen, F., Liu, D., Wang, M., Zhang, S., Kuang, W., Yuan, L., Wang, J., and Liu, G. (2023) Celastrol induces premature ovarian insufficiency by inducing apoptosis in granulosa cells, Biomed. Pharmacother., 169, 115815, \nhttps:\/\/doi.org\/10.1016\/j.biopha.2023.115815.","journal-title":"Biomed. Pharmacother."},{"key":"3097_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.739478","volume":"13","author":"X. Wang","year":"2022","unstructured":"Wang, X., Liu, Q., Wu, S., Xu, N., Li, H., and Feng, A. (2022) Identifying the effect of celastrol against ovarian cancer with network pharmacology and in vitro experiments, Front. Pharmacol., 13, 739478, \nhttps:\/\/doi.org\/10.3389\/fphar.2022.739478.","journal-title":"Front. Pharmacol."},{"key":"3097_CR31","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1111\/cas.14555","volume":"111","author":"Q. Chen","year":"2020","unstructured":"Chen, Q., Shen, H., Zhu, X., Liu, Y., Yang, H., Chen, H., Xiong, S., Chi, H., and Xu, W. (2020) A nuclear lncRNA Linc00839 as a Myc target to promote breast cancer chemoresistance via PI3K\/AKT signaling pathway, Cancer Sci., 111, 3279-3291, \nhttps:\/\/doi.org\/10.1111\/cas.14555.","journal-title":"Cancer Sci."},{"key":"3097_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-022-05469-4","volume":"612","author":"D. Solvie","year":"2022","unstructured":"Solvie, D., Baluapuri, A., Uhl, L., Fleischhauer, D., Endres, T., Papadopoulos, D., Aziba, A., Gaballa, A., Mikicic, I., Isaakova, E., Giansanti, C., Jansen, J., Jungblut, M., Klein, T., Schulein-Volk, C., Maric, H., Doose, S., Sauer, M., Beli, P., Rosenwald, A., et al. (2022) MYC multimers shield stalled replication forks from RNA polymerase, Nature, 612, 148-155, \nhttps:\/\/doi.org\/10.1038\/s41586-022-05469-4.","journal-title":"Nature"}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926601292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297926601292","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926601292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:31:01Z","timestamp":1790951461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297926601292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3097"],"URL":"https:\/\/doi.org\/10.1134\/s0006297926601292","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      This study was performed in line with the principles of Institutional Animal Care and Use Committee (IACUC, 2022). Approval was granted by the Ethics Committee of Jiamusi University (protocol no. JU2024043).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}